151 related articles for article (PubMed ID: 26047368)
21. [Evaluation of bevacizumab combined with irinotecan-based regimen as the first-line treatment for patients with metastatic colorectal cancer].
Lin L; Xu JM; Wang Y; Ge FJ; Liu LJ; Zhao CH; Li SS; Liu JZ; Li ZQ
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):786-90. PubMed ID: 21163073
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
[TBL] [Abstract][Full Text] [Related]
23. CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Tsavaris N; Kosmas C; Papadoniou N; Kopterides P; Tsigritis K; Dokou A; Sarantonis J; Skopelitis H; Tzivras M; Gennatas K; Polyzos A; Papastratis G; Karatzas G; Papalambros A
J Chemother; 2009 Dec; 21(6):673-80. PubMed ID: 20071292
[TBL] [Abstract][Full Text] [Related]
24. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
25. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
26. [A case report of advanced rectal cancer showing a pathological complete response by neo-adjuvant FOLFOX chemotherapy].
Murata A; Inoue T; Maeda K; Noda E; Nagahara H; Kubo N; Tanaka H; Muguruma K; Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2623-5. PubMed ID: 21224659
[TBL] [Abstract][Full Text] [Related]
27. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
[TBL] [Abstract][Full Text] [Related]
28. Normalization of CEA Levels Post-Neoadjuvant Therapy is a Strong Predictor of Pathologic Complete Response in Rectal Cancer.
Kleiman A; Al-Khamis A; Farsi A; Kezouh A; Vuong T; Gordon PH; Vasilevsky CA; Morin N; Faria J; Ghitulescu G; Boutros M
J Gastrointest Surg; 2015 Jun; 19(6):1106-12. PubMed ID: 25859755
[TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer.
Abbas M; Ahmed A; Khan GJ; Baig MMFA; Naveed M; Mikrani R; Cao T; Naeem S; Shi M; Dingding C
Curr Probl Cancer; 2019 Feb; 43(1):5-17. PubMed ID: 30172422
[TBL] [Abstract][Full Text] [Related]
30. Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancer.
Aldulaymi B; Christensen IJ; Sölétormos G; Jess P; Nielsen SE; Laurberg S; Brünner N; Nielsen HJ
Anticancer Res; 2010 Nov; 30(11):4755-9. PubMed ID: 21115936
[TBL] [Abstract][Full Text] [Related]
31. [A case of surgical approach to the recurrence of the para-aortic lymph nodes after resection of rectal cancer].
Fukunaga H; Ota H; Fujie Y; Shimizu K; Ogino T; Toyoda Y; Yoshioka A; Yoshioka S; Hojou S; Endo W; Kakutani A; Maeura Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2204-6. PubMed ID: 20037371
[TBL] [Abstract][Full Text] [Related]
32. Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinoma.
Xu HX; Li S; Wu CT; Qi ZH; Wang WQ; Jin W; Gao HL; Zhang SR; Xu JZ; Liu C; Long J; Xu J; Ni QX; Yu XJ; Liu L
Pancreatology; 2018 Sep; 18(6):671-677. PubMed ID: 30153903
[TBL] [Abstract][Full Text] [Related]
33. CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab.
Petrioli R; Licchetta A; Roviello G; Pascucci A; Francini E; Bargagli G; Conca R; Miano ST; Marzocca G; Francini G;
Cancer Invest; 2012 Jan; 30(1):65-71. PubMed ID: 22236191
[TBL] [Abstract][Full Text] [Related]
34. The utility of monitoring carcinoembyronic antigen during systemic therapy for advanced colorectal cancer.
Grem JL; Steinberg SM; Chen AP; McAtee N; Cullen E; Hamilton JM; Allegra CJ
Oncol Rep; 1998; 5(3):559-67. PubMed ID: 9538153
[TBL] [Abstract][Full Text] [Related]
35. Primary thymic adenocarcinoma with production of carbohydrate antigen 19-9 and carcinoembryonic antigen.
Misao T; Yamamoto Y; Nakano H; Toyooka S; Yamane M; Satoh K
Jpn J Thorac Cardiovasc Surg; 2004 Jan; 52(1):30-2. PubMed ID: 14760989
[TBL] [Abstract][Full Text] [Related]
36. [A successfully resected case of rectal cancer with liver metastases treated with mFOLFOX6 and bevacizumab].
Fujita T; Kawasaki K; Ohno M; Kanaji S; Kobayashi I; Ueno K; Tsuchida S; Osawa M; Fujino Y; Kanbara Y; Nakamura T
Gan To Kagaku Ryoho; 2009 Apr; 36(4):663-6. PubMed ID: 19381044
[TBL] [Abstract][Full Text] [Related]
37. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
[TBL] [Abstract][Full Text] [Related]
38. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions).
Wang L; Zhong XG; Peng YF; Li ZW; Gu J
Colorectal Dis; 2014 Jan; 16(1):33-9. PubMed ID: 23848511
[TBL] [Abstract][Full Text] [Related]
40. [Role of pharmacokinetic monitoring of serum fluorouracil concentration in patients with local advanced and metastatic colorectal cancer and further improving efficacy of fluorouracil-based chemotherapy].
Cai X; Xue P; Song WF; Hu J; Gu HL; Yang HY; Wang LW
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):39-43. PubMed ID: 22490854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
